Patients with COVID-19 and HBV Coinfection are at Risk of Poor Prognosis.
Shan-Shan YangShengshu WangMingmei DuMiao LiuYunxi LiuYao HePublished in: Infectious diseases and therapy (2022)
Patients with COVID-19 coinfected with HBV at the HBeAg (+) CHB/infection stage have an increased risk of poor prognosis, and abnormal liver function partially mediates this increased risk of poor prognosis caused by the coinfection.